Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

BACKGROUND: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)-Lipid study found no evidence of a beneficial effect of statin-fibrate combined treatment, compared to statins alone, on cardiovascular outcomes and mortality in type 2 diabetes mellitus after 5 years of active treatment. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lin, Hayen, Andrew, Bell, Katy J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059389/
https://www.ncbi.nlm.nih.gov/pubmed/32138746
http://dx.doi.org/10.1186/s12933-020-01002-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059389/
https://www.ncbi.nlm.nih.gov/pubmed/32138746
http://dx.doi.org/10.1186/s12933-020-01002-x

Ejemplares similares